BOT 4.23% 37.0¢ botanix pharmaceuticals ltd

Ann: FDA Mid-Cycle Review Meeting Successfully Completed, page-27

  1. 63 Posts.
    lightbulb Created with Sketch. 68
    Will give some time for investors to filter through the outcomes of the mid cycle review. With luck some upward price pressure can accumulate, seller hands wont be too weak and we see a long bar on high volume when the market reopens.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
37.0¢
Change
0.015(4.23%)
Mkt cap ! $669.7M
Open High Low Value Volume
36.0¢ 37.5¢ 35.5¢ $1.465M 4.001M

Buyers (Bids)

No. Vol. Price($)
5 186321 36.0¢
 

Sellers (Offers)

Price($) Vol. No.
37.5¢ 561591 7
View Market Depth
Last trade - 16.10pm 14/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.